We are live on ! Find out more
PDSB icon

PDS Biotechnology
PDSB

80 hedge funds and large institutions have $39.9M invested in PDS Biotechnology in 2023 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 21 increasing their positions, 18 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

72% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 18

18% more funds holding

Funds holding: 68 → 80 (+12)

17% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 18

8% more call options, than puts

Call options by funds: $1.47M | Put options by funds: $1.36M

0.81% more ownership

Funds ownership: 24.93% → 25.74% (+0.81%)

19% less capital invested

Capital invested by funds: $49.4M → $39.9M (-$9.53M)

Holders
80
Holders Change
+12
Holders Change %
+17.65%
% of All Funds
1.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
31
Increased
21
Reduced
18
Closed
18
Calls
$1.47M
Puts
$1.36M
Net Calls
+$112K
Net Calls Change
-$1.9M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$8.34M
2
State Street
State Street
Massachusetts
+$2.32M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$2.14M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.87M
5
Northern Trust
Northern Trust
Illinois
+$1.23M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$3.67M
2
EWA
EP Wealth Advisors
California
-$2.91M
3
Two Sigma Investments
Two Sigma Investments
New York
-$2.32M
4
Renaissance Technologies
Renaissance Technologies
New York
-$2.25M
5
First Manhattan
First Manhattan
New York
-$1.67M
Name Holding Trade Value Shares
Change 		Change in
Stake
NC
76
NewSquare Capital
Pennsylvania
$1.01K – – –
IPW
77
Impact Partnership Wealth
Georgia
$755 +$982 +150 New
IGWM
78
ICA Group Wealth Management
Colorado
$629 +$819 +125 New
TAM
79
Tucker Asset Management
Colorado
$503 -$1.31K -200 -67%
IA
80
IFP Advisors
Florida
$55 – – –
Millennium Management
81
Millennium Management
New York
– -$3.67M -596,272 Closed
First Manhattan
82
First Manhattan
New York
– -$1.67M -271,576 Closed
Qube Research & Technologies (QRT)
83
Qube Research & Technologies (QRT)
United Kingdom
– -$1.24M -201,083 Closed
CSS
84
Cubist Systematic Strategies
Connecticut
– -$1.01M -163,507 Closed
D.E. Shaw & Co
85
D.E. Shaw & Co
New York
– -$1M -162,769 Closed
HF
86
HRT Financial
New York
– -$543K -88,385 Closed
EWA
87
EP Wealth Advisors
California
– -$2.91M -38,337 Closed
TI
88
Trexquant Investment
Connecticut
– -$234K -38,110 Closed
RJFSA
89
Raymond James Financial Services Advisors
Florida
– -$159K -25,918 Closed
LP
90
LMR Partners
United Kingdom
– -$108K -17,520 Closed
TCWM
91
Total Clarity Wealth Management
Illinois
– -$88.3K -14,362 Closed
BFM
92
Boothbay Fund Management
New York
– -$70.8K -11,507 Closed
QT
93
Quantbot Technologies
New York
– -$53.6K -8,722 Closed
Point72 Asset Management
94
Point72 Asset Management
Connecticut
– -$48K -7,811 Closed
PMEF
95
Point72 Middle East FZE
United Arab Emirates
– -$23.2K -3,766 Closed
BAM
96
Belpointe Asset Management
Nevada
– -$4.64K -755 Closed
TWA
97
TCI Wealth Advisors
Arizona
– -$1.23K -200 Closed
Federated Hermes
98
Federated Hermes
Pennsylvania
– -$756 -123 Closed
1 2 3
4

PDSB Hedge Fund Activity: Q2 2023 in Review

80 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in PDS Biotechnology (PDSB) for Q2 2023, worth a combined $39.9M — down 19% from $49.4M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new PDSB positions and 18 closed out — a net gain of 13 holders — while 21 added to existing stakes and 18 trimmed.

The largest buyer was BlackRock, adding an estimated $8.34M. The largest seller was Millennium Management, exiting entirely with an estimated $3.67M sold.

  • 80 institutional investors held PDS Biotechnology (PDSB) as of Q2 2023, up from 68 in Q1 2023.
  • Funds reported $39.9M of PDS Biotechnology stock for Q2 2023, down 19% quarter-over-quarter.
  • 31 funds opened new PDS Biotechnology positions in Q2 2023 and 18 closed out, a net change of +13 holders.
  • The largest PDS Biotechnology buyer in Q2 2023 was BlackRock, an estimated $8.34M added.
  • The largest PDS Biotechnology seller in Q2 2023 was Millennium Management, an estimated $3.67M sold.

Based on aggregated 13F filings for Q2 2023.